DIVERSA has been awarded the prestigious award by the “Deputación da Coruña” among several emerging companies.
The rationale of PEL awards
The PEL awards are part of the Local Employment Plan of the “Deputación da Coruña”. It is a strong commitment to entrepreneurship, innovation in employment, and the promotion of small and medium-sized enterprises as a key stakeholder in the economic development of the Galician province of “A Coruña”.
These types of initiatives seem to have worked perfectly to date throughout the region. In 2021 Galicia created 21% of the biotechnological companies in Spain and established itself as the second most ‘bioentrepreneurial’ region.
DIVERSA: born in Galicia, growing internationally
We are a biotechnological spin-off born at the Health Research Institute of Santiago de Compostela (IDIS) with an innovative proposal in therapeutic molecule delivery.
Our CEO and co-founder Maria de la Fuente, who received the “Best Entrepreneurship Initiative” PEL award at Teatro Jofre Ferrol, leads a team of 14 people to develop a pioneering technology in the world in the field of molecular biology and nanomedicine, generating important therapeutic advances, and opening new hopes and avenues of research in fields such as oncology, metabolic or autoimmune diseases.
What is more, we are so proud that the working team that makes up the company is led by top pharmaceutical and biotechnologist women in their sector. Thanks for recognizing DIVERSA’s potential to bring innovative medicines to market.
If you don’t want to miss our progress, subscribe to our monthly newsletter here!